N/A
N=30
Defining the Conjunctival Staining Method: Instillation Volume and Time Course to Assess Staining With Lissamine Green
Conjunctival Staining
Bottom Line
View on ClinicalTrials.gov: NCT00768898 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Apr 2012
Primary outcome: Primary: Conjunctival Staining at 1 Minute — 3.29; 3.67; 3.98 Units on a scale
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- 2.5/5.0/10.0 µL lissamine green (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Alcon Research
- Primary completion
- Sep 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Conjunctival Staining at 1 Minute |
3.29; 3.67; 3.98 | — |
| PRIMARY Conjunctival Staining at 2 Minutes |
3.67; 4.29; 4.64 | — |
| PRIMARY Conjunctival Staining at 3 Minutes |
3.02; 3.88; 4.12 | — |
| PRIMARY Conjunctival Staining at 4 Minutes |
2.48; 3.14; 3.69 | — |
| PRIMARY Conjunctival Staining at 5 Minutes |
2.12; 2.67; 3.10 | — |
Summary
The purpose of this study is to determine the correct volume of lissamine green to use when assessing conjunctival staining, and to determine the time course needed to evaluate conjunctival staining after lissamine green has been instilled in the eye.
Eligibility Criteria
Inclusion Criteria
- conjunctival staining
Exclusion Criteria
- ocular pathology
Data sourced from ClinicalTrials.gov (NCT00768898). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.